Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.61 |
| ▸ | MAPT | P10636 | 5/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.61 |
| ▸ | GAA | P10253 | 2/20 | 0.61 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.61 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | THRB | P10828 | 2/20 | 0.55 |
| ▸ | RECQL | P46063 | 2/20 | 0.55 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.55 |
| ▸ | KDR | P35968 | 2/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28596944 | 0.83 | KDM4E (0.61) | ALDH1A1KDM4EMAPTCYP3A4GAA | |
| SCHEMBL19972042 | 0.81 | MAPT (0.44) | ALDH1A1KDM4EMAPTCYP3A4GAA | |
| SCHEMBL231377 | 0.79 | ALDH1A1 (0.68) | ALDH1A1KDM4EMAPTCYP3A4GAA | |
| SCHEMBL29364937 | 0.79 | ALDH1A1 (0.68) | ALDH1A1KDM4EMAPTCYP3A4GAA | |
| Hydrochloric Acid SCHEMBL11879331 | 0.79 | MAPT (0.42) | ALDH1A1KDM4EMAPTCYP3A4GAA | |
| SCHEMBL715406 | 0.77 | KDM4E (0.65) | ALDH1A1KDM4EMAPTCYP3A4GAA | |
| SCHEMBL7295418 | 0.77 | KDM4E (0.65) | ALDH1A1KDM4EMAPTCYP3A4GAA | |
| SCHEMBL28520448 | 0.77 | ALDH1A1 (0.65) | ALDH1A1KDM4EMAPTCYP3A4GAA | |
| SCHEMBL2810654 | 0.77 | ALDH1A1 (0.65) | ALDH1A1KDM4EMAPTCYP3A4GAA | |
| SCHEMBL588405 | 0.77 | PTPN1 (0.48) | ALDH1A1KDM4EMAPTCYP3A4GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150290344-A1 | BIODEGRADABLE POLYESTER- AND POLY(ESTER AMIDE) BASED X-RAY IMAGING AGENTS | CLEMSON UNIVERSITY RESEARCH FOUNDATION | 2015-10-15 | — | — | US | claimed |
| EP-4688005-A1 | POLYURETHANE-BASED RADIOPAQUE CROSSLINKED HYDROGELS WITH NON-ISOCYANATE PRECURSOR FOR MEDICAL APPLICATIONS | Boston Scientific Scimed Inc. (US) | 2026-02-11 | — | — | EP | disclosed |
| WO-2024206223-A1 | POLYURETHANE-BASED RADIOPAQUE CROSSLINKED HYDROGELS WITH NON-ISOCYANATE PRECURSOR FOR MEDICAL APPLICATIONS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2024-10-03 | — | — | WO | disclosed |
| US-20240317944-A1 | POLYURETHANE-BASED RADIOPAQUE CROSSLINKED HYDROGELS WITH NON-ISOCYANATE PRECURSOR FOR MEDICAL APPLICATIONS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2024-09-26 | — | — | US | disclosed |
| US-11579526-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-02-14 | — | — | US | disclosed |
| US-20220281866-A1 | 5,8-DISUBSTITUTED-[1,2,4]TRIAZOLO[1,5-A]PYRIDINYL AND 5,8-DISUBSTITUTED-IMIDAZO[1,2-A]PYRIDINE DERIVATIVES USEFUL AS INHIBITORS OF ENTEROPEPTIDASE | JANSSEN PHARMACEUTICA NV (BE) | 2022-09-08 | — | — | US | disclosed |
| WO-2021013742-A1 | 5,8-DISUBSTITUTED-[1,2,4]TRIAZOLO[1,5-A]PYRIDINYL AND 5,8-DISUBSTITUTED-IMIDAZO[1,2-A]PYRIDINE DERIVATIVES USEFUL AS INHIBITORS OF ENTEROPEPTIDASE | JANSSEN PHARMACEUTICA NV (BE) | 2021-01-28 | — | — | WO | disclosed |
| US-20200301274-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-09-24 | — | — | US | disclosed |
| US-20150290344-A1 | BIODEGRADABLE POLYESTER- AND POLY(ESTER AMIDE) BASED X-RAY IMAGING AGENTS | CLEMSON UNIVERSITY RESEARCH FOUNDATION | 2015-10-15 | — | — | US | disclosed |
| WO-2012030907-A1 | DI-AZETIDINYL DIAMIDE AS MONOACYLGLYCEROL LIPASE INHIBITORS | JANSSEN PHARMACEUTICA NV (BE) | 2012-03-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150290344-A1 | BIODEGRADABLE POLYESTER- AND POLY(ESTER AMIDE) BASED X-RAY IMAGING AGENTS | PUF60, ARG1, PAM | ALDH1A1 3356/4885KDM4E 831/4885MAPT 1630/4885 |
| US-20220281866-A1 | 5,8-DISUBSTITUTED-[1,2,4]TRIAZOLO[1,5-A]PYRIDINYL AND 5,8-DISUBSTITUTED-IMIDAZO[1,2-A]PYRIDINE DERIVATIVES USEFUL AS INHIBITORS OF ENTEROPEPTIDASE | TMPRSS15, DPP8, SI | ALDH1A1 620/4885KDM4E 1990/4885MAPT 2544/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.